当前位置:首页 - 行情中心 - 尔康制药(300267) - 财务分析 - 资产负债表

尔康制药

(300267)

  

流通市值:64.72亿  总市值:93.85亿
流通股本:14.22亿   总股本:20.63亿

资产负债表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
流动资产:
  货币资金976,834,945.24897,404,913.83709,202,365.93492,515,859.62
  交易性金融资产90,000,00090,000,00090,000,00060,000,000
  衍生金融资产--762,746.79-
  应收票据及应收账款163,181,967.78155,784,775.56158,238,311.24186,741,635.39
  其中:应收票据33,964,991.334,792,695.9128,718,737.5224,038,250.13
        应收账款129,216,976.48120,992,079.65129,519,573.72162,703,385.26
  应收款项融资38,942,196.8646,609,251.1746,348,208.743,202,655.2
  预付款项43,456,373.734,342,448.497,711,330.9426,581,613.81
  其他应收款合计3,529,862.483,622,884.223,763,018.263,795,220.47
  存货523,930,100.38511,995,309.66574,294,141.02625,389,003.86
  其他流动资产79,273,211.6178,805,318.31183,743,187.05177,773,363.42
  流动资产合计1,919,148,658.081,788,564,901.241,774,063,309.931,615,999,351.77
非流动资产:
  长期股权投资49,753,379.5249,796,115.4371,902,577.3471,738,178.56
  其他权益工具投资50,000,00050,000,00050,000,00050,000,000
  投资性房地产74,075,724.6774,877,094.5275,678,464.3276,479,834.15
  固定资产2,024,647,726.092,052,034,605.352,287,013,221.832,329,876,053.71
  在建工程203,474,658.59212,280,768.93225,861,386.29193,497,744.49
  使用权资产156,221,733.02161,011,810.33164,980,432.62166,245,543.3
  无形资产312,643,182.3317,123,214.89348,585,635.76353,852,829.2
  商誉2,003,166.562,003,166.562,003,166.562,003,166.56
  长期待摊费用8,889,167.49,562,210.3110,266,723.1110,982,868.74
  递延所得税资产119,801,334.85120,402,235.4148,136,132.48148,619,262.29
  其他非流动资产38,830,879.7223,368,123.2444,181,917.9930,596,047.96
  非流动资产合计3,040,340,952.723,072,459,344.963,428,609,658.33,433,891,528.96
  资产总计4,959,489,610.84,861,024,246.25,202,672,968.235,049,890,880.73
流动负债:
  短期借款684,508,487.65551,383,098.76484,025,320.99310,082,500
  衍生金融负债---3,943,429.92
  应付票据及应付账款113,472,017.86121,072,034.17108,436,127.25130,879,711.62
        应付账款113,472,017.86121,072,034.17108,436,127.25130,879,711.62
  合同负债39,538,415.3726,174,437.9937,899,091.0234,459,211.16
  应付职工薪酬12,414,386.7725,007,592.28,987,8558,781,917.63
  应交税费3,136,590.678,745,803.432,574,431.763,006,654.27
  其他应付款合计40,467,336.5444,163,226.0629,060,465.4926,334,744.18
  一年内到期的非流动负债4,823,476.18,787,182.798,897,807.256,297,340.06
  其他流动负债18,545,378.4417,393,561.3112,424,291.1610,082,426.3
  流动负债合计916,906,089.4802,726,936.71692,305,389.92533,867,935.14
非流动负债:
  租赁负债27,715,257.227,858,917.4127,645,980.8328,693,744.25
  预计负债--12,993,511.8812,993,511.88
  递延收益9,197,888.2910,059,027.0111,261,165.5912,463,304.34
  递延所得税负债46,354,118.3846,324,267.5246,427,163.8146,424,423.65
  非流动负债合计83,267,263.8784,242,211.9498,327,822.11100,574,984.12
  负债合计1,000,173,353.27886,969,148.65790,633,212.03634,442,919.26
所有者权益(或股东权益):
  实收资本(或股本)2,062,604,8702,062,604,8702,062,604,8702,062,604,870
  资本公积1,019,459,930.441,019,459,930.441,019,459,930.441,019,459,930.44
  其他综合收益1,494,544.0926,858,716.6142,711,554.7244,763,936.08
  专项储备1,236,897.271,096,278.591,153,611.57986,452.65
  盈余公积138,000,248.18138,000,248.18138,000,248.18138,000,248.18
  未分配利润799,381,775.12786,273,191.361,205,666,707.231,203,725,458.17
  归属于母公司股东权益合计4,022,178,265.14,034,293,235.184,469,596,922.144,469,540,895.52
  少数股东权益-62,862,007.57-60,238,137.63-57,557,165.94-54,092,934.05
  股东权益合计3,959,316,257.533,974,055,097.554,412,039,756.24,415,447,961.47
  负债和股东权益合计4,959,489,610.84,861,024,246.25,202,672,968.235,049,890,880.73
公告日期2026-04-242026-04-232025-10-302025-08-28
审计意见(境内)标准无保留意见
TOP↑